Lck-IN-2
Lck-IN-2 (compound 12a) is an inhibitor of Lymphocyte-specific protein tyrosine kinase (Lck) with IC50 of 10.6 nM. Lck-IN-2 reveals efficacy in colon cancer cells with GI50s of 0.24-1.26 μM. Lck-IN-2 exhibits an apoptotic effect in Colo201 cells[1].
Product Specifications
CAS Number
2615173-24-3
UNSPSC
12352005
Target
Apoptosis; Src
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lck-in-2.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=C(C=C1N2CC3=C(N(C2=O)C)N=C(N=C3)NC4=CN=C(C=C4)C)NC(C5=CC=C(C(OCC(C)C)=C5)[N+]([O-])=O)=O
Molecular Formula
C31H32N8O5
Molecular Weight
596.64
References & Citations
[1]Hyun Ji S, et al., Identification of 3,4-dihydropyrimido[4,5-d]pyrimidin-2 (1H) -one scaffolds as potent Lck inhibitors as anti-cancer agents. Bioorg Med Chem Lett. 2024 Feb 3:129645.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Lck
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
73410 25 Preparations
EXTRAClean Plasma/Serum Exosome and Free-Circulating RNA Isolation Midi Kit
Sign In for Pricing
View Details 
TA-2107-2 2 mL
Texas Red Conjugated Goat Polyclonal Antibody to Human Kappa (Free Bence Jones)
Sign In for Pricing
View Details 